Clinicopathological Profiles and Prognosis of Postoperative HER2-Mutant Non-Small Cell Lung Cancer: A Real-World Analysis.
BACKGROUND/INTRODUCTION Patients with non-small cell lung cancer (NSCLC) harboring HER2 mutations remain at high risk of recurrence, even following radical resection for early-stage disease. Currently, there is a paucity of research investigating the clinicopathological characteristics and disease-free survival (DFS) o...